Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial
Authors
Susan M. van den Berg
Birgit E. P. J. Vriens
Rhodé M. Bijlsma (ORCID: https://orcid.org/0000-0003-0980-6652)
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial
Susan M. van den Berg, Birgit E. P. J. Vriens, Rhodé M. Bijlsma, Monique E.M.M. Bos et al.
Citations
1 citations
Journal
EClinicalMedicine
Topics
Cancer Treatment and Pharmacology
Field-Weighted Citation Impact (FWCI)
1.05
article
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial
Susan M. van den Berg, Birgit E. P. J. Vriens, Rhodé M. Bijlsma, Monique E.M.M. Bos, Esther Oomen‐de Hoop, Niels A.D. Guchelaar, Peter Nieboer, Joan B. Heijns, Mandy M van Rosmalen, Karin Beelen, Lonneke W. Kessels, Ron H.J. Mathijssen, Marlies L. van Bekkum, Lisanne C. Hamming, Maaike de Boer
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 80
Institutions
Radboud University Nijmegen (NL), Breast Cancer Research Foundation (US), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Centrum Leeuwarden (NL), University Medical Center Utrecht (NL), Reinier de Graaf Hospital (NL), Amphia Ziekenhuis (NL), Cancer Genomics Centre (NL), Erasmus MC Cancer Institute (NL), Rijnstate Hospital (NL), Deventer Ziekenhuis (NL), Maastro Clinic (NL)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial — Susan M. van den Berg, Birgit E. P. J. Vriens, et al. · EClinicalMedicine (2025) | TGRS Research Map | TGRS